Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN

1 Jan 2016

Abstract excerpt

This review revises the reclassification of the membranoproliferative glomerulonephritis (MPGN) after the consensus conference that by 2015 reclassified all the glomerulonephritis basing on etiology and pathogenesis, instead of the histomorphological aspects. After reclassification, two types of MPGN are to date recognized: The immunocomplexes mediated MPGN and the complement mediated MPGN. The latter type is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Complement system in diseases
Share to Renal Diseases and Glomerulopathies
Share to Vasculitis and related conditions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27458560
DOI: 10.5527/wjn.v5.i4.308

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GNPMID 27458560Read ↗

Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatmentSemantic proximity Read ↗

Pathogenesis of the C3 glomerulopathies and reclassification of MPGNSemantic proximity Read ↗

C3 glomerulopathy: what's in a name?Semantic proximity Read ↗

Acquired and genetic determinants of disease phenotype and therapeutic strategies in C3 glomerulopathy and immunoglobulin-associated MPGNSemantic proximity Read ↗

C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic.Semantic proximity Read ↗

C3 Glomerulopathy: A Current Perspective in an Evolving LandscapeSemantic proximity Read ↗

Clinico-Pathogenic Similarities and Differences between Infection-Related Glomerulonephritis and C3 GlomerulopathySemantic proximity Read ↗

C3 glomerulopathy: a new classificationSemantic proximity Read ↗

Targeted Complement Treatments in Glomerulopathies: A Comprehensive ReviewSemantic proximity Read ↗

Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.Semantic proximity Read ↗

Complement catalyzing glomerular diseasesSemantic proximity Read ↗

Genetic and acquired abnormalities in C3 glomerulopathy and primary immune complex-mediated MPGNSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.